10 Best “Strong Buy” Stocks — IPXL PANW TNK and more

This week, these ten stocks, all currently earning A’s (“strong buy”) on Portfolio Grader, have the best year-to-date performance.

Since January 1, Impax Laboratories, Inc. (IPXL) has shot up 57.2%. Impax Laboratories develops, manufactures, and markets both proprietary and multi-source pharmaceutical products utilizing its drug delivery technologies. For more information, get Portfolio Grader’s complete analysis of IPXL stock.

Since January 1, the price of Palo Alto Networks, Inc. (PANW) has grown 58.3%. Palo Alto Networks offers a next-generation network security platform that allows enterprises, service providers, and government entities to secure their networks. For more information, get Portfolio Grader’s complete analysis of PANW stock.

The price of Teekay Tankers Ltd. Class A (TNK) is up 59.6% since the first of the year. Teekay Tankers owns oil tankers and transports crude oil. For more information, get Portfolio Grader’s complete analysis of TNK stock.

Since January 1, Sucampo Pharmaceuticals, Inc. Class A (SCMP) has jumped 62.5%. Sucampo Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization of proprietary drugs based on prostones, a class of compounds derived from functional fatty acids that occur naturally in the human body. For more information, get Portfolio Grader’s complete analysis of SCMP stock.

Since January 1, the price of China Biologic Products, Inc. (CBPO) has grown 74.4%. China Biologic Products is a biopharmaceutical company that engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers. For more information, get Portfolio Grader’s complete analysis of CBPO stock.

Since the first of the year, shares of Ebix, Inc. (EBIX) have soared 78.4%. Ebix provides a series of application software products for the insurance industry, including carrier systems and agency systems. For more information, get Portfolio Grader’s complete analysis of EBIX stock.

The price of Ellie Mae, Inc. (ELLI) has seen an 83.4% boost since the first of the year. Ellie Mae provides business automation software for the mortgage industry in the United States. Trade volume has increased significantly over the past week, up 195.3%. For more information, get Portfolio Grader’s complete analysis of ELLI stock.

The price of ABIOMED, Inc. (ABMD) is up 99.2% since the first of the year. Abiomed provides medical devices in circulatory support and it offers a continuum of care in heart recovery to acute heart failure patients. For more information, get Portfolio Grader’s complete analysis of ABMD stock.

Since January 1, Skechers U.S.A., Inc. Class A (SKX) has climbed 117.7%. Skechers USA designs, makes, markets and distributes footwear. For more information, get Portfolio Grader’s complete analysis of SKX stock.

Chimera Investment Corporation (CIM) has risen 308.8% since the first of the year. Chimera Investment is a specialty finance company that invests in residential mortgage-backed securities, residential mortgage loans, real estate-related securities, and various other asset classes. The volume of trades has grown significantly in the past week, up 116.7%. The stock currently has a trailing PE Ratio of 5.20. For more information, get Portfolio Grader’s complete analysis of CIM stock.

Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.


Article printed from InvestorPlace Media, https://investorplace.com/2015/07/10-best-strong-buy-stocks-ipxl-panw-tnk-and-more-ipxl-panw-tnk/.

©2022 InvestorPlace Media, LLC